CeNeRx BioPharma cenerx.com


CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clinical-stage therapeutics for the treatment of depression, anxiety and epilepsy and a preclinical pipeline of selective cannabinoid compounds for treating pain, glaucoma and spasticity.

CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clinical-stage therapeutics for the treatment of depre...Show all

Company (Dead / Inactive)

Phone: 919-523-0489

Fax:

270 Cornerstone DR
Suite 103
Cary, 27519
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CeNeRx BioPharma $64.6M Jun 20, 2013
Astex Therapeutics $0M Jul 21, 2011
Replidyne $121.5M Feb 25, 2009
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CeNeRx BioPharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide Jul 05, 2007 Oct 12, 2010 Patent